| |
| |
|
| Insider
Information: |
Moretti August J |
| Relationship: |
|
| City: |
Palo Alto |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
137,329 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$78,542 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
137,329 |
|
|
| Total
Value |
$78,542 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alexza Pharmaceuticals Inc. |
ALXA |
Former SVP, CFO, GC & ... |
2011-08-31 |
51,837 |
|
0 |
Premium* |
|
|
Assertio Holdings Inc |
ASRT |
Chief Financial Office... |
2018-03-31 |
74,447 |
2013-05-17 |
0 |
Premium* |
|
|
4d Molecular Therapeutics Inc. |
FDMT |
|
2023-05-15 |
11,045 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
42 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALXA |
Alexza Pharmaceuticals In... |
SVP, CFO & SecOfficer |
• – – |
2006-03-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
4,999 |
|
- |
|
| FDMT |
4d Molecular Therapeutics... |
See RemarksOfficer |
• – – |
2020-12-10 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,000 |
|
- |
|
| ALXA |
Alexza Pharmaceuticals In... |
SVP, CFO & Sec |
• – – |
2007-08-01 |
4 |
GD |
$0.00 |
$0 |
D/D |
375 |
7,120 |
0 |
- |
|
| ALXA |
Alexza Pharmaceuticals In... |
SVP, CFO & Sec |
• – – |
2009-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
24,419 |
33,923 |
0 |
- |
|
| ALXA |
Alexza Pharmaceuticals In... |
SVP, CFO, GC & Sec |
• – – |
2011-01-19 |
4 |
A |
$0.00 |
$0 |
D/D |
45,582 |
92,691 |
0 |
- |
|
| ALXA |
Alexza Pharmaceuticals In... |
Former SVP, CFO, GC & Sec |
• – – |
2011-08-31 |
5 |
GD |
$0.00 |
$0 |
D/D |
2,000 |
51,837 |
0 |
- |
|
| ALXA |
Alexza Pharmaceuticals In... |
SVP, CFO & Sec |
• – – |
2009-12-17 |
4/A |
AS |
$2.20 |
$5,405 |
D/D |
(2,456) |
40,295 |
0 |
- |
|
| ALXA |
Alexza Pharmaceuticals In... |
SVP, CFO & Sec |
• – – |
2009-12-17 |
4 |
AS |
$2.20 |
$5,407 |
D/D |
(2,457) |
40,291 |
0 |
- |
|
| ALXA |
Alexza Pharmaceuticals In... |
SVP, CFO & Sec |
• – – |
2007-08-01 |
4 |
OE |
$1.38 |
$6,900 |
D/D |
5,000 |
12,495 |
0 |
- |
|
| ALXA |
Alexza Pharmaceuticals In... |
SVP, CFO & Sec |
• – – |
2007-10-01 |
4 |
OE |
$1.38 |
$6,900 |
D/D |
5,000 |
12,120 |
0 |
- |
|
| ALXA |
Alexza Pharmaceuticals In... |
SVP, CFO & Sec |
• – – |
2008-01-02 |
4 |
OE |
$1.38 |
$6,900 |
D/D |
5,000 |
13,874 |
0 |
- |
|
| ALXA |
Alexza Pharmaceuticals In... |
SVP, CFO & Sec |
• – – |
2008-04-01 |
4 |
OE |
$1.38 |
$6,900 |
D/D |
5,000 |
13,874 |
0 |
- |
|
| FDMT |
4d Molecular Therapeutics... |
Chief Financial Officer |
• – – |
2021-04-12 |
4 |
OE |
$9.41 |
$9,410 |
D/D |
1,000 |
2,000 |
0 |
- |
|
| ALXA |
Alexza Pharmaceuticals In... |
SVP, CFO & Sec |
• – – |
2009-12-16 |
4/A |
AS |
$2.41 |
$10,668 |
D/D |
(4,432) |
42,751 |
0 |
- |
|
| ALXA |
Alexza Pharmaceuticals In... |
SVP, CFO & Sec |
• – – |
2009-12-16 |
4 |
AS |
$2.41 |
$10,675 |
D/D |
(4,435) |
42,748 |
0 |
- |
|
| ASRT |
Assertio Holdings Inc |
Chief Financial Officer & SVP |
• – – |
2017-04-02 |
4 |
D |
$12.55 |
$11,797 |
D/D |
(940) |
41,785 |
0 |
- |
|
| ASRT |
Assertio Holdings Inc |
Chief Financial Officer |
• – – |
2013-05-17 |
4 |
OE |
$5.35 |
$13,375 |
D/D |
2,500 |
3,752 |
0 |
- |
|
| ASRT |
Assertio Holdings Inc |
Chief Financial Officer & SVP |
• – – |
2016-04-02 |
4 |
D |
$14.38 |
$13,517 |
D/D |
(940) |
27,879 |
0 |
- |
|
| ALXA |
Alexza Pharmaceuticals In... |
SVP, CFO & Sec |
• – – |
2007-04-02 |
4 |
OE |
$1.38 |
$13,800 |
D/D |
10,000 |
15,741 |
0 |
- |
|
| ALXA |
Alexza Pharmaceuticals In... |
SVP, CFO & Sec |
• – – |
2009-12-18 |
4/A |
AS |
$2.13 |
$15,127 |
D/D |
(7,112) |
33,183 |
0 |
- |
|
| ALXA |
Alexza Pharmaceuticals In... |
SVP, CFO & Sec |
• – – |
2009-12-18 |
4 |
AS |
$2.13 |
$15,137 |
D/D |
(7,117) |
33,174 |
0 |
- |
|
| ALXA |
Alexza Pharmaceuticals In... |
SVP, CFO & Sec |
• – – |
2006-12-07 |
4 |
S |
$8.30 |
$16,600 |
D/D |
(2,000) |
5,741 |
0 |
- |
|
| ASRT |
Assertio Holdings Inc |
Chief Financial Officer |
• – – |
2013-12-02 |
4 |
AS |
$8.40 |
$23,709 |
D/D |
(2,821) |
11,214 |
0 |
- |
|
| ASRT |
Assertio Holdings Inc |
Chief Financial Officer & SVP |
• – – |
2015-12-16 |
4 |
OE |
$5.35 |
$26,750 |
D/D |
5,000 |
26,319 |
0 |
- |
|
| FDMT |
4d Molecular Therapeutics... |
Chief Financial Officer |
• – – |
2022-12-21 |
4 |
OE |
$9.41 |
$28,230 |
D/D |
3,000 |
6,595 |
0 |
- |
|
42 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
